A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)
Hyun Ae Jung, Miso Kim, Hae Su Kim, Joo-Hang Kim, Yoon Hee Choi, Jinhyun Cho, Ji Hyun Park, Keon Uk Park, Bo Mi Ku, Sehhoon Park, Jong‐Mu Sun, Se‐Hoon Lee, Jin Seok Ahn, Keunchil Park, Myung‐Ju Ahn
Topics & Concepts
MedicinePalbociclibThymic carcinomaRefractory (planetary science)Internal medicineChemotherapyOncologyPhases of clinical researchSarcomaClinical endpointProgressive diseaseGastroenterologySurgeryUrologyCancerClinical trialPathologyBreast cancerAstrobiologyMetastatic breast cancerPhysicsAdvanced Breast Cancer TherapiesMyasthenia Gravis and ThymomaGastrointestinal Tumor Research and Treatment